Axxcess Wealth Management’s Lucid Diagnostics LUCD Stock Holding History

Axxcess Wealth Management’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.7K	Buy	+18,254	New	+$17.1K	﹤0.01%	981

Other funds holding LUCD

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Traphagen Investment Advisors Oradell, New Jersey $1.46B AUM 14.92% 1-Year Est. Return

Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return

Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.72% 1-Year Est. Return

Obermeyer Wealth Partners Aspen, Colorado $2.51B AUM 18.87% 1-Year Est. Return

Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Quaker Wealth Management Moorestown, New Jersey $341M AUM 9.06% 1-Year Est. Return

Axxcess Wealth Management's LUCD Position: Q3 2026 in Review

Axxcess Wealth Management opened a new position in Lucid Diagnostics (LUCD) in Q3 2026: 18,254 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #981 among its holdings.

15 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

Axxcess Wealth Management held 18,254 shares of Lucid Diagnostics worth $13.7K as of Q3 2026.
Lucid Diagnostics was a new Axxcess Wealth Management position in Q3 2026.
Lucid Diagnostics made up ﹤0.01% of Axxcess Wealth Management's portfolio in Q3 2026, its #981 holding.
15 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on Axxcess Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.